Cover Image
Market Research Report
Product code
873280

Mesenchymal Stem Cells Market, : Market Size & Forecast, 2018 - 2026

Published: | Polaris Market Research | 110 Pages | Delivery time: 1-2 business days

Price

Back to Top
Mesenchymal Stem Cells Market, : Market Size & Forecast, 2018 - 2026
Published: March 1, 2019
Polaris Market Research
Content info: 110 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

The global mesenchymal stem cells market size to reach USD 2,518.5 Million by 2026, growing at a CAGR of 7.0% during forecast period, according to a new research report published by Polaris Market Research. The report 'Mesenchymal Stem Cells Market, [By Source (Bone Marrow, Umbilical Cord Blood, Peripheral Blood, Lung Tissue, Synovial Tissues, Amniotic Fluids, Adipose Tissues); By Application (Injuries, Drug Discovery, Cardiovascular Infraction, Others); By Region]: Market Size & Forecast, 2018 - 2026' provides an extensive analysis of present market dynamics and predicted future trends. The market was valued at USD 1,335.1 million in 2017. In 2017, the drug discovery application dominated the market, in terms of revenue. North America region is observed to be the leading contributor in the global market revenue in 2017.

are adult stem cells, which are traditionally found in the bone marrow. However, they can also be parted from other available tissues including peripheral blood, cord blood, fallopian tube. These stem cells mainly function for the replacement of damaged cell and tissues. The potential of these cell is to heal the damaged tissue with no pain to the individual. Scientists are majorly focusing on developing new and innovative treatment options for the various chronic diseases like cancer. Additionally, the local governments have also taken various steps for promoting the use of these stem cells.

The significant aspects that are increasing the development in market for mesenchymal stem cells consist of enhancing need for these stem cells as an efficient therapy option for knee replacement. Raising senior populace throughout the world, as well as increasing frequency of numerous persistent conditions consisting of cancer cells, autoimmune illness, bone and cartilage diseases are elements anticipated to enhance the market development throughout the forecast period. The mesenchymal stem cells market is obtaining favorable assistance by the reliable federal government policies, as well as funding for R&D activities which is anticipated to influence the market growth over coming years. According to the reports released by world health organization (WHO), by 2050 individuals aged over 60 will certainly make up greater than 20% of the globe's population. Of that 20%, a traditional quote of 15% is estimated to have symptomatic OA, as well as one-third of these individuals are expected to be influenced by extreme specials needs. Taking into consideration all these aspects, the market for mesenchymal stem cells will certainly witness a substantial development in the future.

Increasing demand for better healthcare facilities, rising geriatric population across the globe, and continuous research and development activities in this area by the key players is expected to have a positive impact on the growth of Mesenchymal Stem Cells market. North America generated the highest revenue in 2017, and is expected to be the leading region globally during the forecast period. The Asia Pacific market is also expected to witness significant market growth in coming years. Developing healthcare infrastructure among countries such as China, India in this region is observed to be the major factor promoting the growth of this market during the forecast period.

The major key players operating in the industry are Cell Applications, Inc., Cyagen Biosciences Inc. Axol Bioscience Ltd., Cytori Therapeutics Inc., Stem cell technologies Inc., Celprogen, Inc. BrainStorm Cell Therapeutics, Stemedica Cell Technologies, Inc. These companies launch new products and undertake strategic collaboration and partnerships with other companies in this market to expand presence and to meet the increasing needs and requirements of consumers.

Polaris Market Research has segmented the global mesenchymal stem cells market on the basis of source type, application and region:

Mesenchymal Stem Cells Source Type Outlook (Revenue, USD Million, 2015 - 2026)

Bone Marrow

Umbilical Cord Blood

Peripheral Blood

Lung Tissue

Synovial Tissues

Amniotic Fluids

Adipose Tissues

Mesenchymal Stem Cells Application Outlook (Revenue, USD Million, 2015 - 2026)

Injuries

Drug Discovery

Cardiovascular Infraction

Others

Mesenchymal Stem Cells Regional Outlook (Revenue, USD Million, 2015 - 2026)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Rest of Europe

Asia-Pacific

China

India

Japan

Singapore

Malaysia

Australia

Rest of Asia-Pacific

Latin America

Mexico

Brazil

Argentina

Rest of LATAM

Middle East & Africa

Table of Contents
Product Code: PM1565

Table of Contents

1. Overview and Scope

  • 1.1. Research goal & scope
  • 1.2. Research assumptions
  • 1.3. Research Methodology
    • 1.3.1. Primary data sources
    • 1.3.2. Secondary data sources
  • 1.4. Key take-away
  • 1.5. Stakeholders

2. Executive Summary

  • 2.1. Market Definition
  • 2.2. Market Segmentation

3. Mesenchymal Stem Cells Market Insights

  • 3.1. Mesenchymal Stem Cells - Industry snapshot
  • 3.2. Mesenchymal Stem Cells - Ecosystem analysis
  • 3.3. Mesenchymal Stem Cells Market Dynamics
    • 3.3.1. Mesenchymal Stem Cells - Market Forces
    • 3.3.2. Mesenchymal Stem Cells Market Driver Analysis
    • 3.3.3. Mesenchymal Stem Cells Market Restraint/Challenges analysis
    • 3.3.4. Mesenchymal Stem Cells Market Opportunity Analysis
  • 3.4. Industry analysis - Porter's five force
    • 3.4.1. Bargaining power of supplier
    • 3.4.2. Bargaining power of buyer
    • 3.4.3. Threat of substitute
    • 3.4.4. Threat of new entrant
    • 3.4.5. Degree of competition
  • 3.5. Mesenchymal Stem Cells Market PEST Analysis
  • 3.6. Mesenchymal Stem Cells Market Value Chain Analysis
  • 3.7. Mesenchymal Stem Cells Industry Trends
  • 3.8. Competitive Ranking Analysis

4. Mesenchymal Stem Cells Market Size and Forecast by Source Type, 2018-2026

  • 4.1. Key Findings
  • 4.2. Bone Marrow
  • 4.3. Umbilical Cord Blood
  • 4.4. Peripheral Blood
  • 4.5. Lung Tissue
  • 4.6. Synovial Tissues
  • 4.7. Amniotic Fluids
  • 4.8. Adipose Tissues.

5. Mesenchymal Stem Cells Market Size and Forecast by Application Type, 2018-2026

  • 5.1. Key Findings
  • 5.2. Injuries
  • 5.3. Drug Discovery
  • 5.4. Cardiovascular Infraction
  • 5.5. Others

6. Mesenchymal Stem Cells Market Size and Forecast by Region, 2018-2026

  • 6.1. Key Findings
  • 6.2. North America
    • 6.2.1. U. S.
    • 6.2.2. Canada
  • 6.3. Europe
    • 6.3.1. Germany
    • 6.3.2. UK
    • 6.3.3. France
    • 6.3.4. Italy
    • 6.3.5. Spain
    • 6.3.6. Russia
    • 6.3.7. Rest of Europe
  • 6.4. Asia-Pacific
    • 6.4.1. China
    • 6.4.2. India
    • 6.4.3. Japan
    • 6.4.4. Singapore
    • 6.4.5. Malaysia
    • 6.4.6. Australia
    • 6.4.7. Rest of Asia-Pacific
  • 6.5. Latin America
    • 6.5.1. Mexico
    • 6.5.2. Brazil
    • 6.5.3. Argentina
    • 6.5.4. Rest of LATAM
  • 6.6. Middle East & Africa

7. Company Profiles

  • 7.1. Cell Applications, Inc.
    • 7.1.1. Overview
    • 7.1.2. Financials
    • 7.1.3. Product Benchmarking
    • 7.1.4. Recent Developments
  • 7.2. Cyagen Biosciences Inc.
    • 7.2.1. Overview
    • 7.2.2. Financials
    • 7.2.3. Product Benchmarking
    • 7.2.4. Recent Developments
  • 7.3. Axol Bioscience Ltd.
    • 7.3.1. Overview
    • 7.3.2. Financials
    • 7.3.3. Product Benchmarking
    • 7.3.4. Recent Developments
  • 7.4. Cytori Therapeutics Inc.
    • 7.4.1. Overview
    • 7.4.2. Financials
    • 7.4.3. Product Benchmarking
    • 7.4.4. Recent Developments
  • 7.5. Stem cell technologies Inc.
    • 7.5.1. Overview
    • 7.5.2. Financials
    • 7.5.3. Product Benchmarking
    • 7.5.4. Recent Developments
  • 7.6. Celprogen, Inc.
    • 7.6.1. Overview
    • 7.6.2. Financials
    • 7.6.3. Product Benchmarking
    • 7.6.4. Recent Developments
  • 7.7. BrainStorm Cell Therapeutics.
    • 7.7.1. Overview
    • 7.7.2. Financials
    • 7.7.3. Product Benchmarking
    • 7.7.4. Recent Developments
  • 7.8. Stemedica Cell Technologies, Inc.
    • 7.8.1. Overview
    • 7.8.2. Financials
    • 7.8.3. Product Benchmarking
    • 7.8.4. Recent Developments